Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Dario Eklund
Oliver Kronenberg
Catherine Isted
Geert Jan van Daal
Marc Schrader
Shabir Hasham
Board:
Melanie Rolli
Shabir Hasham
Bradley Meyer
Philipp Gutzwiller
Thomas Meier
Shareholding in %:
Andrew P. Smith 0.34
Catalyst Pharmaceuticals, Inc. 10.1
Dario Eklund 0.79
Equinor Asset Management ASA 0.32
Idorsia Ltd. 2.88
Santhera Pharmaceuticals Holding AG 4.44
Shabir Hasham 0.33
Thomas Meier 0.35
UBS Asset Management Switzerland AG 1.86
Zürcher Kantonalbank (Investment Management) 1.52
Freefloat 77.06
Address: Hohenrainstrasse 24, 4133 Pratteln
T: +41-61-906-89-50
F: +41-61-906-89-51
I: http://www.santhera.com
E: office@santhera.com